Grants Leslie T. Cooper, M.D. | Grant Number | Funding Institution | Grant Title | Duration | | 1 RO1 HL056267-01 | National Heart, Lung and Blood Institute | Autoimmune Determinants of Human Cardiac Myosin | 8/1/08-7/31/13 | | 1 R01 HL75038-01 | National Heart, Lung and Blood Institute | Peripartum Cardiomyopathy Registry | 1/1/10-12/31/11 | Gregory A. Poland, M.D. | Grant Number | Funding Institution | Grant Title | Duration | | RO1 AI48793-01 | National Institutes of Health | Immunogenetics of Rubella Vaccine Response | 2006-2011 | | RO1 AI33144-6 | National Institute of Allergy and Infectious Diseases | The Immunogenetics of Measles Immunity | 2008-2013 | | N01 AI40065 | National Institute of Allergy and Infectious Diseases | Population Genetics Analysis Program: Immunity to Vaccines/Infections | 2004-2010 | | FED CDC#5-3 | Centers for Disease Control and Prevention | CDC#5-MOD #10 | 2005-2010 | | R21CA 123839-2 | National Institutes of Health | Measles Virotherapy for Glioblastom Multiforme | 2006-2010 | | RO1 AI48793-01 | National Institutes of Health | Immunogenetics of Rubella Vaccine Response | 2006-2011 | | RO1 AI33144-6 | National Institutes of Allergy and Infectious Diseases | The Immunogenetics of Measles Immunity | 2008-2013 | | R015-20040-S1-1 | National Institutes of Health | A Phase I Randomized Study of the Safety, Dose Escalation, and Immunogenicity of Adjuvanted Influenza Anhui/H5 Boosting in Subjects Previously | 2009-2010 | Robin Patel, M.D. | Grant Number | Funding Institution | Grant Title | Duration | | R01 AR056647 | National Institute of Arthritis and Musculoskeletal and Skin Diseases | Molecular detection of biofilms on hip and knee implants | 7/01/2009-4/30/14 | | R41 AR052944 | National Institute of Arthritis and Musculoskeletal and Skin Diseases | Detection of biofilm bacteria using GloBac | 7/01/2008-6/30/10 | Eric M. Poeschla, M.D. | Grant Number | Funding Institution | Grant Title | Duration | | 1 R01 EY14411 | National Institute of Health | Eicosanoid Gene Therapy | 3/1/2008-2/29/2012 | | 1 R01 AI77433 | National Institute of Health | LEDGF/p75 and HIV Replication | 5/1/2008-4/30/2013 | | — | University of Minnesota & Mayo Partnership for Biotechnology and Medical Genomics grant | Targeting Human LEDGF/p75 and APOBEC3G for Treatment of HIV/AIDS | 2007-2010 | Lewis R. Roberts, Ph.D. | Grant Number | Funding Institution | Grant Title | Duration | | R01 CA100882 | National Institute of Health | Molecular Pathogenesis of Hepatocellular Carcinoma | 3/1/04-2/28/09 | | R21CA128633-1 | National Institute of Health | Dysregulation of the Tumor Microenvironment in Hepatocellular Carcinoma | 8/19/09-7/31/11 | | — | Bristol-Myers-Squibb Pharmaceuticals | The BRIDGE Study to Better Understanding of Outcomes | 11/1/08-4/30/13 | | — | MDS Nordion | Survival of Patients Receiving Yttrium-90 Microspheres versus Chemoembolization | 11/1/08-4/30/10 | | — | KL2 Award | The Occult Hepatitis B Coinfection with Hepatitis C as a Risk Factor for Hepatocellular Carcinoma in Somali Immigrants: Role of Viral Genetics and Epigenetics and the Immune Response | 3/1/09-2 | Andrew D. Badley, M.D. | Grant Number | Funding Institution | Grant Title | Duration | | R01 AI40384-04AD | National Institute of Allergy and Infectious Diseases | Regulation of HIV-Mediated CD4 T Cell Apoptosis | 1/1/2007-12/31/2011 | | UL1 RR 24150 -3 | National Center for Research Resources | Mayo Clinic Center for Clinical and Translational Research | 9/30/2006-6/30/2011 |
|
